Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7304 | 1306 | 47.2 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1572 | 6695 | LEUKOARAIOSIS//WHITE MATTER LESIONS//WHITE MATTER HYPERINTENSITIES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VASCULAR RISK FACTORS | Author keyword | 10 | 17% | 4% | 54 |
2 | BRAIN HYPOPERFUSION | Author keyword | 9 | 55% | 1% | 12 |
3 | HOP BROCA | Address | 7 | 31% | 1% | 19 |
4 | CLIN NEUROSCIDEMENTIA GRP | Address | 3 | 60% | 0% | 3 |
5 | APOLIPOPROTEIN E4 ALLELE APOE4 | Author keyword | 2 | 67% | 0% | 2 |
6 | MEMORY CLIN CMRR | Address | 2 | 67% | 0% | 2 |
7 | W HAROLD CIVIN NEUROPATHOL | Address | 2 | 67% | 0% | 2 |
8 | FRAMINGHAM STROKE RISK PROFILE | Author keyword | 2 | 50% | 0% | 3 |
9 | JOHN JAMES S | Address | 2 | 40% | 0% | 4 |
10 | VASCULAR FACTORS | Author keyword | 1 | 19% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MIDLIFE BLOOD PRESSURE | 33 | 42% | 5% | 62 |
2 | KUNGSHOLMEN PROJECT | 20 | 32% | 4% | 53 |
3 | ANTIHYPERTENSIVE MEDICATION USE | 17 | 51% | 2% | 24 |
4 | VASCULAR RISK FACTORS | 14 | 13% | 8% | 101 |
5 | WILLIS ATHEROSCLEROSIS | 8 | 52% | 1% | 11 |
6 | DCP1 | 6 | 47% | 1% | 9 |
7 | SYST EUR TRIAL | 5 | 54% | 1% | 7 |
8 | INCIDENT ALZHEIMER DISEASE | 5 | 15% | 2% | 32 |
9 | TOTAL CHOLESTEROL LEVEL | 5 | 30% | 1% | 14 |
10 | ELDERLY PROGRAM SHEP | 5 | 23% | 1% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms | 2015 | 4 | 80 | 51% |
The age-dependent relation of blood pressure to cognitive function and dementia | 2005 | 372 | 120 | 71% |
A major role for cardiovascular burden in age-related cognitive decline | 2015 | 3 | 155 | 46% |
Association between Stroke and Alzheimer's Disease: Systematic Review and Meta-Analysis | 2015 | 4 | 49 | 31% |
Cognitive Impairment Associated With Atrial Fibrillation A Meta-analysis | 2013 | 39 | 41 | 39% |
The projected effect of risk factor reduction on Alzheimer's disease prevalence | 2011 | 359 | 82 | 13% |
Future directions in Alzheimer's disease from risk factors to prevention | 2014 | 21 | 83 | 23% |
Midlife cardiovascular risk factors and risk of dementia in late life | 2005 | 386 | 33 | 36% |
Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies | 2015 | 4 | 157 | 19% |
Arterial stiffness, the brain and cognition: A systematic review | 2014 | 11 | 62 | 34% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HOP BROCA | 7 | 31% | 1.5% | 19 |
2 | CLIN NEUROSCIDEMENTIA GRP | 3 | 60% | 0.2% | 3 |
3 | MEMORY CLIN CMRR | 2 | 67% | 0.2% | 2 |
4 | W HAROLD CIVIN NEUROPATHOL | 2 | 67% | 0.2% | 2 |
5 | JOHN JAMES S | 2 | 40% | 0.3% | 4 |
6 | ABERDEEN ROYAL HOSP | 1 | 38% | 0.2% | 3 |
7 | DEMENTIA GRPJOHN JAMES SFRENCHAY HOSP | 1 | 100% | 0.2% | 2 |
8 | FAMILY MED CARDIOL | 1 | 50% | 0.2% | 2 |
9 | POST MED EDUC PGIMER | 1 | 100% | 0.2% | 2 |
10 | UNIV HOSP NEUROL PSYCHIAT ST NAUM | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000262456 | COGNIT AGING MEMORY//SUMMA HLTH SYST//SYSTEMIC PERFUSION |
2 | 0.0000223924 | VASCULAR DEMENTIA//POSTSTROKE DEMENTIA//VASCULAR COGNITIVE IMPAIRMENT |
3 | 0.0000174034 | NEUROPSYCHOLOGICAL IMPROVEMENT//NEUROPSYCHOMETRIC//SCI NEUROSURG |
4 | 0.0000165857 | LEUKOARAIOSIS//WHITE MATTER LESIONS//WHITE MATTER HYPERINTENSITIES |
5 | 0.0000163773 | PREDEMENTIA SYNDROMES//OLDER SMOKERS//SPHL BEHAV COMMUNITY HLTH |
6 | 0.0000152340 | INTRANASAL INSULIN//PATHOCHEM GEN NEUROCHEM//DIABETIC ENCEPHALOPATHY |
7 | 0.0000120793 | CHRONIC CEREBRAL HYPOPERFUSION//PERMANENT OCCLUSION OF BILATERAL COMMON CAROTID ARTERIES//CEREBRAL HYPOPERFUSION |
8 | 0.0000107775 | 24S HYDROXYCHOLESTEROL//CYP46//24 HYDROXYCHOLESTEROL |
9 | 0.0000099912 | PSYCHIAT PAOLO OTTONELLO//STANFORD VA AGING CLIN//ALZHEIMERS DIS CORE NEURODEGENERAT DIS |
10 | 0.0000097671 | MINICHAL//ANTIHYPERTENSIVE DRUG CLASSES//ANTIHYPERTENSIVE REGIMENS |